Depreciation of Editas Medicine, Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Editas Medicine, Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • Editas Medicine, Inc. Depreciation for the quarter ending 31 Mar 2025 was $1,917,000, a 36% increase year-over-year.
  • Editas Medicine, Inc. annual Depreciation for 2025 was $5,277,000, a 9.2% decline from 2024.
  • Editas Medicine, Inc. annual Depreciation for 2024 was $5,809,000, a 4.2% decline from 2023.
  • Editas Medicine, Inc. annual Depreciation for 2023 was $6,064,000, a 4.3% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Editas Medicine, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $5,277,000 -$532,000 -9.2% 01 Jan 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
2024 $5,809,000 -$255,000 -4.2% 01 Jan 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
2023 $6,064,000 -$273,000 -4.3% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2025 2024 FY
2022 $6,337,000 +$1,284,000 +25% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2025 2024 FY
2021 $5,053,000 +$1,094,000 +28% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $3,959,000 +$1,129,000 +40% 01 Jan 2020 31 Dec 2020 10-K 22 Feb 2023 2022 FY
2019 $2,830,000 -$424,000 -13% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $3,254,000 +$571,000 +21% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
2017 $2,683,000 +$1,481,000 +123% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
2016 $1,202,000 +$731,000 +155% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
2015 $471,000 +$314,000 +200% 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2018 2017 FY
2014 $157,000 01 Jan 2014 31 Dec 2014 10-K 03 Mar 2017 2016 FY

Editas Medicine, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,917,000 +$508,000 +36% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q1 2024 $1,409,000 -$135,000 -8.7% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q1 2023 $1,544,000 -$14,000 -0.9% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $1,558,000 +$395,000 +34% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q1 2021 $1,163,000 +$365,000 +46% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $798,000 +$170,000 +27% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $628,000 -$123,000 -16% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q1 2018 $751,000 +$120,000 +19% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $631,000 +$444,000 +237% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018 2018 Q1
Q1 2016 $187,000 +$104,000 +125% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q1 2015 $83,000 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.